Cart
sales@molnova.com
Murepavadin TFA
CAS No. ——
Murepavadin TFA ( POL7080 TFA )
Catalog No. M29749 CAS No. ——
Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameMurepavadin TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionMurepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
-
DescriptionMurepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
-
In Vitro——
-
In Vivo——
-
SynonymsPOL7080 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorP. aeruginosa
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1667.83
-
Molecular FormulaC73H112N22O16.C2HF3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Cyclo(Ala-Ser-{d-Pro}-Pro-Thr-Trp-Ile-{Dab}-{Orn}-{d-Dab}-{Dab}-Trp-{Dab}-{Dab})
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Matteo Bassetti, et al. New antibiotics for ventilator-associated pneumonia. Curr Opin Infect Dis. 2018 Jan 13.
molnova catalog
related products
-
Sulbutiamine
Sulbutiamine is an antioxidant that act by inhibiting oxidative stress induced retinal ganglion cell death.
-
24-Dihydroxypyridine
24-Dihydroxypyridine is a chemical compound.
-
3-Epiursolic acid
3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.
